News

Preannouncement - 2025 Joint Transnational Call for Proposals on Rare Disease Therapies

Published on | 1 year ago

Programmes
Health

The European Partnership on Rare Diseases (ERDERA) has preannounced its first Joint Transnational Call for Proposals on Rare Disease Therapies. The content of the preannouncement may be subject to change.

The call will formally open on 10 December and will have a two-stage submission process with deadline for pre-proposals in February 2025 and full proposal deadline in July 2025.

Research Foundation Flanders (FWO) participates in this call. More information on available funding for researchers based in Flanders and on who can apply & how will become available on the FWO website after official opening of the call.

The primary objective of the call is to support interdisciplinary, transnational collaborations that leverage complementary expertise to develop new therapies for rare diseases. Research projects should focus on pre-clinical studies involving small molecules or biologicals. This could include the development of novel therapies, biomarkers for therapy efficiency, or replication of pre-clinical studies to validate findings.

More information is available on the ERDERA website.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1863 articles available search in articles 

Testimonial

image of ONELAB: City of Hasselt contribute to development of Rapid Response Mobile Labs

ONELAB: City of Hasselt contribute to development of Rapid Response Mobile Labs

The City of Hasselt took part in the ONELAB project (2022–2025) as an end user. The project was funded under Horizon Europe (HORIZON-CL3-2021-DRS-01-05) and focused on developing modular Rapid Response Mobile Laboratories (RRML). These laboratories are designed for rapid deployment in a variety of settings to support disease monitoring.